Skip to contentCormorant Private Healthcare Fund III LP — IMARX THERAPEUTICS INC insider: 16 transactions · InsiderLensCormorant Private Healthcare Fund III LP
- 10% owner at MoonLake Immunotherapeutics · on record since Oct 10, 2023
- 10% owner at OnKure Therapeutics, Inc. · on record since Oct 15, 2024
- Former 10% Owner at OnKure Therapeutics, Inc. · on record since May 19, 2025
- Former 10% Holder at Biomea Fusion, Inc. · on record since Aug 1, 2025
- Former 10% Owner at MoonLake Immunotherapeutics · on record since Oct 1, 2025
- 10% owner at HIGHLAND BUSINESS SERVICES, INC. · on record since Jun 24, 2021
- Former 10% Owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- 10% owner at Tyra Biosciences, Inc. · on record since Sep 14, 2021
- 10% owner at Biomea Fusion, Inc. · on record since Apr 22, 2021
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 22, 2021
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 16, 2021
- Former 10% Owner at Design Therapeutics, Inc. · on record since Apr 1, 2021
- 10% owner at IMARX THERAPEUTICS INC · on record since Jul 29, 2021
- 10% owner at Olema Pharmaceuticals, Inc. · on record since Nov 23, 2020
- 10% owner at Design Therapeutics, Inc. · on record since Mar 25, 2021
- 10% owner at Ignyta, Inc. · on record since Mar 18, 2021
- Former 10% Owner at Ignyta, Inc. · on record since Mar 18, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- Former 10% Owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 29, 2021
- 10% owner at Icosavax, Inc. · on record since Jul 28, 2021
- Former 10% Owner at Tyra Biosciences, Inc. · on record since Sep 21, 2021
- Former 10% Owner at Icosavax, Inc. · on record since Aug 4, 2021
- 10% owner at Ventyx Biosciences, Inc. · on record since Oct 27, 2021
- Former 10% Owner at Pyxis Oncology, Inc. · on record since Oct 15, 2021
- 10% owner at Pyxis Oncology, Inc. · on record since Oct 7, 2021
- 10% owner at Ambrx Biopharma Inc. · on record since Mar 16, 2023
Insider trading activity of Cormorant Private Healthcare Fund III LP
- Transactions on record
- 16
- since Apr 19, 2021
- Open-market buys
- 6
- $35.5M
- Open-market sells
- 9
- $4.5M
- Companies traded
- 4
- last filing May 19, 2025
Figures computed from official regulatory filings — methodology.
Companies where Cormorant Private Healthcare Fund III LP has traded
Track record of Cormorant Private Healthcare Fund III LP
Statistical track record
Free- Open-market buys
- 6
- Last buy
- Apr 17, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Cormorant Private Healthcare Fund III LP
Co-insiders of Cormorant Private Healthcare Fund III LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
MoonLake Immunotherapeutics +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 19, 2025 | Sell | -1,813,439 | 1.85 USD | $3.4M | SEC |
| Apr 3, 2024 | Sell | -10 | 2.98 USD | $29.8 | SEC |
| Apr 3, 2024 | Sell | -600 | 3.03 USD | $1.8K | SEC |
| Apr 3, 2024 | Sell | -10 | 3.01 USD | $30.1 | SEC |
| Apr 3, 2024 | Sell | -100 | 3.07 USD | $307 | SEC |
| Apr 3, 2024 | Sell | -280 | 2.97 USD | $831.6 | SEC |
| Apr 3, 2024 | Sell | -398,600 | 2.90 USD | $1.2M | SEC |
| Apr 3, 2024 | Sell | -300 | 3.07 USD | $921 | SEC |
| Apr 3, 2024 | Sell | -100 | 3.05 USD | $305 | SEC |
| Apr 17, 2023 | Buy | 1,193,808 | 9.16 USD | $10.9M | SEC |
| Apr 17, 2023 | Buy | 562,121 | 10.67 USD | $6M | SEC |
| Apr 17, 2023 | Buy | 841,967 | 9.96 USD | $8.4M | SEC |
| Mar 16, 2023 | Buy | 500,000 | 10.15 USD | $5.1M | SEC |
| Mar 16, 2023 | Buy | 250,000 | 10.60 USD | $2.7M | SEC |
| Mar 16, 2023 | Buy | 250,000 | 9.95 USD | $2.5M | SEC |
| Apr 19, 2021 | AwardD | -28,911 | 0.00 USD | $0 | SEC |